1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceuticals in Taiwan

Pharmaceuticals in Taiwan

  • April 2014
  • -
  • MarketLine
  • -
  • 37 pages

Introduction

Pharmaceuticals in Taiwan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Taiwan pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2013 annual average exchange rates.

*The Taiwanese pharmaceuticals market had total revenues of $5.1bn in 2013, representing a compound annual growth rate (CAGR) of 5.5% between 2009 and 2013.

*Taiwan's ageing population is likely help the pharmaceutical market achieve accelerated growth in the short-term.

*The performance of the market is forecast to accelerate, with an anticipated CAGR of 7.6% for the five-year period 2013 - 2018, which is expected to drive the market to a value of $7.4bn by the end of 2018.

Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Taiwan

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Taiwan

Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Taiwan pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Taiwan economy

Key Questions Answered

What was the size of the Taiwan pharmaceuticals market by value in 2013?

What will be the size of the Taiwan pharmaceuticals market in 2018?

What factors are affecting the strength of competition in the Taiwan pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in Taiwan's pharmaceuticals market?

Table Of Contents

Pharmaceuticals in Taiwan
TABLE OF CONTENTS

Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Geography segmentation 9
Market share 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 15
New entrants 16
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
Merck and Co., Inc. 20
Novartis AG 23
Pfizer Inc. 27
Sanofi SA 30
Macroeconomic Indicators 33
Country Data 33
Appendix 35
Methodology 35
Industry associations 36
Related MarketLine research 36

LIST OF TABLES

Table 1: Taiwan pharmaceuticals market value: $ billion, 2009-13 8
Table 2: Taiwan pharmaceuticals market geography segmentation: $ billion, 2013 9
Table 3: Taiwan pharmaceuticals market share: % share, by value, 2013 10
Table 4: Taiwan pharmaceuticals market value forecast: $ billion, 2013-18 11
Table 5: Merck and Co., Inc.: key facts 20
Table 6: Merck and Co., Inc.: key financials ($) 21
Table 7: Merck and Co., Inc.: key financial ratios 21
Table 8: Novartis AG: key facts 23
Table 9: Novartis AG: key financials ($) 24
Table 10: Novartis AG: key financial ratios 25
Table 11: Pfizer Inc.: key facts 27
Table 12: Pfizer Inc.: key financials ($) 28
Table 13: Pfizer Inc.: key financial ratios 28
Table 14: Sanofi SA: key facts 30
Table 15: Sanofi SA: key financials ($) 31
Table 16: Sanofi SA: key financials (€) 31
Table 17: Sanofi SA: key financial ratios 31
Table 18: Taiwan size of population (million), 2009-13 33
Table 19: Taiwan gdp (constant 2000 prices, $ billion), 2009-13 33
Table 20: Taiwan gdp (current prices, $ billion), 2009-13 33
Table 21: Taiwan inflation, 2009-13 34
Table 22: Taiwan consumer price index (absolute), 2009-13 34
Table 23: Taiwan exchange rate, 2009-13 34

LIST OF FIGURES

Figure 1: Taiwan pharmaceuticals market value: $ billion, 2009-13 8
Figure 2: Taiwan pharmaceuticals market geography segmentation: % share, by value, 2013 9
Figure 3: Taiwan pharmaceuticals market share: % share, by value, 2013 10
Figure 4: Taiwan pharmaceuticals market value forecast: $ billion, 2013-18 11
Figure 5: Forces driving competition in the pharmaceuticals market in Taiwan, 2013 12
Figure 6: Drivers of buyer power in the pharmaceuticals market in Taiwan, 2013 13
Figure 7: Drivers of supplier power in the pharmaceuticals market in Taiwan, 2013 15
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Taiwan, 2013 16
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Taiwan, 2013 18
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Taiwan, 2013 19
Figure 11: Merck and Co., Inc.: revenues and profitability 21
Figure 12: Merck and Co., Inc.: assets and liabilities 22
Figure 13: Novartis AG: revenues and profitability 25
Figure 14: Novartis AG: assets and liabilities 26
Figure 15: Pfizer Inc.: revenues and profitability 29
Figure 16: Pfizer Inc.: assets and liabilities 29
Figure 17: Sanofi SA: revenues and profitability 32
Figure 18: Sanofi SA: assets and liabilities 32

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.